IPF » Trang Công Nghệ | Trangcongnghe.vn

European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU

Globe Newswire

European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU

Globenewswire -

New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

Globe Newswire

New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

Globenewswire -

CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU

Globe Newswire

CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU

Globenewswire -

JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment

Globe Newswire

JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment

Globenewswire -

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Globe Newswire

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Globenewswire -

JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)

Globe Newswire

JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)

Globenewswire -

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

Globe Newswire

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

Globenewswire -

XEM THÊM TIN MỚI